Skip to main content

Animations

MJFF Publications

2171 - 2180 of 6295 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2019
  • 2020
  • 2020
  • 2019
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Artificial intelligence within the interplay between natural and artificial computation: Advances in data science, trends and applications
    Journal Name: Neurocomputing
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.neucom.2020.05.078
    Citation Count: 240
  • Summary Details
    OPEN
    Title: Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273R
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2020.105079
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuron.2020.02.034
    Citation Count: 202
  • Summary Details
    OPEN
    Title: New transgenic models of Parkinson's disease using genome editing technology
    Journal Name: Neurología (English Edition)
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nrleng.2017.08.006
    Citation Count: 3
  • Summary Details
    OPEN
    Title: The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenant
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.027
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.04.002
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Parkinson's disease motor subtype changes during 20 years of follow-up
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.024
    Citation Count: 30
  • Summary Details
    OPEN
    Title: A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerability
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.020
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Genetic characterization of Parkinson's disease patients in Ecuador and Colombia
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.005
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Co-Existence of tau and α-synuclein pathology in fetal graft tissue at autopsy: A case report
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.013
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.